Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · Advisors

O'Shaughnessy Market Leaders Value Fund (OFVIX)

Ticker OFVIX · Since 2016-02-26 · · Holdings as of Jul 31, 2026

Expense ratio
0.55%$55/yr per $10k
5-yr return
+12.7%annualized
1-yr return
+23.9%as of Dec 2024
Net assets
$287.4Mall share classes
Holdings
69

Bottom line

Is OFVIX a good fund? The bottom line

OFVIX is an actively managed large value mutual fund from Advisors.

It charges 0.55% — about $55 a year on every $10,000 invested, cheaper than 78% of large value funds we track.

It returned +23.9% over one year, +12.7% a year over five years (as of Dec 31, 2024, per its prospectus).

With $287 million in net assets and 69 holdings, its largest position is General Motors Co (4.5%) and the top 10 make up 35.3% of the portfolio.

What stands out

  • Low cost: cheaper than 78% of large value peers
  • 5-year return beat 77% of category peers

Updated Nov 19, 2026

What OFVIX invests in

The OShaughnessy Market Leaders Value Funds (the Fund) investment objective is to seek long-term capital appreciation and current income.

Under normal market conditions, the Fund invests primarily in a diversified portfolio of common stocks and other equity securities of companies of all sizes, including but not limited to, American Depositary Receipts (ADRs), preferred stocks, limited partnerships, and convertible securities. OShaughnessy Asset Management, LLC (the Adviser) employs a bottom-up, quantitative, factor-based approach to security selection based on research and analysis of historical data. The Adviser may eliminate or substitute factors at its discretion. Portfolio securities may be sold generally upon periodic rebalancing of the Funds portfolio. For selling decisions, the Adviser considers the same factors it uses in evaluating a security for purchase and generally sells securities when it believes such securities no longer meet its investment criteria. The Fund may from time to time emphasize investment in…

From the fund's prospectus (filed Nov 25, 2025).

OFVIX performance

Fund calendar-year total returns, 2017–2024 2017: +24.6%; 2018: −12.9%; 2019: +26.0%; 2020: +1.8%; 2021: +30.5%; 2022: −6.2%; 2023: +17.8%; 2024: +23.9% +25% 2017 −13% 2018 +26% 2019 +2% 2020 +30% 2021 −6% 2022 +18% 2023 +24% 2024
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
OFVIX+23.9%+12.7%—
Large Value median+13.6%+11.3%+10.2%

Source: Fund prospectus, as of Dec 31, 2024

Full OFVIX performance history →

What OFVIX costs

On a $10,000 investment, OFVIX's 0.55% expense ratio costs about $55 a year. The prospectus estimates $689 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full OFVIX fee table →

OFVIX top 10 holdings

#Holding% of fund
1General Motors Co GM4.47%
2Altria Group Inc MO4.46%
3Synchrony Financial SYF4.24%
4HCA Healthcare Inc HCA3.60%
5DR Horton Inc DHI3.57%
6Kraft Heinz Co/The KHC3.30%
7M&T Bank Corp MTB3.18%
8MetLife Inc MET3.13%
9Comcast Corp CMCSA2.75%
10Tapestry Inc TPR2.57%

Source: SEC Form N-PORT, period ended Jul 31, 2026

The top 10 make up 35.3% of the fund. See all top 25 holdings and asset mix →

Alternatives to OFVIX

More funds like OFVIX →

OFVIX FAQ

What is the expense ratio of OFVIX?
OFVIX's expense ratio is 0.55%, which works out to about $55 a year for every $10,000 invested. The prospectus estimates total costs of $689 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is OFVIX a good investment?
It depends on your goals, but the data points to: low cost: cheaper than 78% of large value peers; 5-year return beat 77% of category peers. This is general information, not personalized advice.
What does OFVIX hold?
OFVIX's largest holdings are General Motors Co (4.5%), Altria Group Inc (4.5%), Synchrony Financial (4.2%), HCA Healthcare Inc (3.6%), DR Horton Inc (3.6%). It holds 69 positions in total as of Jul 31, 2026 (SEC Form N-PORT).
What is OFVIX's 5-year return?
OFVIX returned +12.7% a year over the five years ending Dec 31, 2024. Past performance does not guarantee future results.
Who manages OFVIX?
OFVIX is offered by Advisors through Advisors Series Trust.